Naresh Kanumilli

990 total citations · 1 hit paper
19 papers, 323 citations indexed

About

Naresh Kanumilli is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and General Health Professions. According to data from OpenAlex, Naresh Kanumilli has authored 19 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Cardiology and Cardiovascular Medicine and 3 papers in General Health Professions. Recurrent topics in Naresh Kanumilli's work include Diabetes Treatment and Management (8 papers), Diabetes Management and Research (7 papers) and Chronic Disease Management Strategies (3 papers). Naresh Kanumilli is often cited by papers focused on Diabetes Treatment and Management (8 papers), Diabetes Management and Research (7 papers) and Chronic Disease Management Strategies (3 papers). Naresh Kanumilli collaborates with scholars based in United Kingdom, United States and Canada. Naresh Kanumilli's co-authors include Lalantha Leelarathna, Hood Thabit, Nicola Milne, Emma G. Wilmot, Darren M. Ashcroft, Gerry Rayman, Rachel Elliott, Alison K. Wright, Martin K. Rutter and Georgios Gkountouras and has published in prestigious journals such as New England Journal of Medicine, BMC Public Health and Drugs.

In The Last Decade

Naresh Kanumilli

18 papers receiving 318 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes

2022 108 citations Lalantha Leelarathna, Mark L. Evans et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Naresh Kanumilli United Kingdom	9	227	94	82	44	40	19	323
Ulagamathesan Venkatesan India	12	194 0.9×	49 0.5×	68 0.8×	67 1.5×	30 0.8×	46	399
Sopio Tatulashvili France	11	122 0.5×	54 0.6×	29 0.4×	46 1.0×	30 0.8×	34	357
Faruque Pathan Bangladesh	9	215 0.9×	56 0.6×	58 0.7×	36 0.8×	16 0.4×	29	347
Enrique Fluiters Spain	11	233 1.0×	128 1.4×	31 0.4×	44 1.0×	31 0.8×	16	429
Samar Banerjee India	10	183 0.8×	93 1.0×	32 0.4×	39 0.9×	17 0.4×	29	345
Abdullah Alkandari Kuwait	9	105 0.5×	45 0.5×	51 0.6×	52 1.2×	13 0.3×	19	325
Osamah M. Alfayez Saudi Arabia	9	170 0.7×	66 0.7×	31 0.4×	24 0.5×	5 0.1×	31	312
Vishwanath Pattan United States	10	91 0.4×	48 0.5×	27 0.3×	48 1.1×	7 0.2×	32	302
Miguel Contreras Venezuela	6	62 0.3×	107 1.1×	47 0.6×	47 1.1×	10 0.3×	7	305
Maureen Clement Canada	10	290 1.3×	69 0.7×	35 0.4×	69 1.6×	54 1.4×	15	379

Countries citing papers authored by Naresh Kanumilli

Since Specialization

Citations

This map shows the geographic impact of Naresh Kanumilli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naresh Kanumilli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naresh Kanumilli more than expected).

Fields of papers citing papers by Naresh Kanumilli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naresh Kanumilli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naresh Kanumilli. The network helps show where Naresh Kanumilli may publish in the future.

Co-authorship network of co-authors of Naresh Kanumilli

This figure shows the co-authorship network connecting the top 25 collaborators of Naresh Kanumilli. A scholar is included among the top collaborators of Naresh Kanumilli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naresh Kanumilli. Naresh Kanumilli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Rutter, Martin K., Matthew Carr, Alison K. Wright, et al.. (2024). Indirect effects of the COVID-19 pandemic on diagnosing, monitoring, and prescribing in people with diabetes and strategies for diabetes service recovery internationally. Diabetes Research and Clinical Practice. 212. 111693–111693. 1 indexed citations

Seidu, Samuel, Sarah Davies, Philip Newland‐Jones, et al.. (2024). SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review. Diabetes Therapy. 15(5). 1099–1124. 17 indexed citations

Kanumilli, Naresh, et al.. (2024). The role of finerenone in the management of CKD in T2D –Practical considerations for primary care. Primary care diabetes. 18(6). 565–573.

Pecoits‐Filho, Roberto, Ana Cebrián, Rafael Santamaría, et al.. (2024). High Prevalence of Unrecorded Stage 3 Chronic Kidney Disease in Australia, Brazil, Canada, England, and Spain: The Multinational, Observational REVEAL‐CKD Study. International Journal of Clinical Practice. 2024(1). 1 indexed citations

Tangri, Navdeep, Christian S. Álvarez, Matthew Arnold, et al.. (2024). Suboptimal monitoring and management in patients with unrecorded stage 3 chronic kidney disease in real‐world settings: Insights from REVEAL‐CKD. European Journal of Clinical Investigation. 54(11). e14282–e14282. 3 indexed citations

Vora, Jiten, David Z.I. Cherney, Mikhail Kosiborod, et al.. (2024). Inter‐relationships between cardiovascular, renal and metabolic diseases: Underlying evidence and implications for integrated interdisciplinary care and management. Diabetes Obesity and Metabolism. 26(5). 1567–1581. 8 indexed citations

Kanumilli, Naresh, Javed Butler, Konstantinos Makrilakis, et al.. (2023). Guardians For Health: A Practical Approach to Improving Quality of Life and Longevity in People with Type 2 Diabetes. Diabetes Therapy. 14(7). 1093–1110. 3 indexed citations

Lam, Carolyn S.P., Alex Chin, Naresh Kanumilli, et al.. (2023). Identification of urgent gaps in public and policymaker knowledge of heart failure: Results of a global survey. BMC Public Health. 23(1). 1023–1023. 8 indexed citations

Goldthorpe, Joanna, Thomas Allen, Joanna Brooks, et al.. (2022). Digital Interventions Supporting Self-care in People With Type 2 Diabetes Across Greater Manchester (Greater Manchester Diabetes My Way): Protocol for a Mixed Methods Evaluation. JMIR Research Protocols. 11(8). e26237–e26237. 1 indexed citations

10.

Leelarathna, Lalantha, Mark L. Evans, Sankalpa Neupane, et al.. (2022). Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes. New England Journal of Medicine. 387(16). 1477–1487. 108 indexed citations breakdown →

11.

Carr, Matthew, Alison K. Wright, Lalantha Leelarathna, et al.. (2021). Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes: a UK-wide cohort study involving 618 161 people in primary care. BMJ Quality & Safety. 31(7). 503–514. 59 indexed citations

12.

Wilmot, Emma G., Mark L. Evans, Katharine Barnard‐Kelly, et al.. (2021). Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocol. BMJ Open. 11(7). e050713–e050713. 10 indexed citations

13.

Evans, Marc, Angharad R. Morgan, Zaheer Yousef, et al.. (2021). Optimising the Heart Failure Treatment Pathway: The Role of SGLT2 Inhibitors. Drugs. 81(11). 1243–1255. 3 indexed citations

14.

Farmer, Ruth, et al.. (2021). Prescribing in Type 2 Diabetes Patients With and Without Cardiovascular Disease History: A Descriptive Analysis in the UK CPRD. Clinical Therapeutics. 43(2). 320–335. 38 indexed citations

15.

Kanumilli, Naresh, Stephen Brunton, Xavier Cos, et al.. (2020). Global survey investigating causes of treatment inertia in type 2 diabetes cardiorenal risk management. Journal of Diabetes and its Complications. 35(3). 107813–107813. 11 indexed citations

16.

Farmer, Ruth, et al.. (2020). PDB59 Prescribing Patterns in Type 2 Diabetes By Cardiovascular Disease History: A Descriptive Analysis in the UK Clinical Practice Research Datalink. Value in Health. 23. S515–S516. 1 indexed citations

17.

Verma, Subodh, Abhinav Sharma, Naresh Kanumilli, & Javed Butler. (2019). Predictors of heart failure development in type 2 diabetes. Current Opinion in Cardiology. 34(5). 578–583. 16 indexed citations

18.

Chudleigh, Richard, et al.. (2019). Establishing Expert, Multi-Disciplinary, Peer-Reviewed Consensus to Lead a Paradigm Shift in Optimal Blood Glucose Management. Diabetes Therapy. 10(3). 901–916. 2 indexed citations

19.

Kanumilli, Naresh, Richard I. G. Holt, Cathy E. Lloyd, et al.. (2018). Language matters. Addressing the use of language in the care of people with diabetes: position statement of the English Advisory Group. Diabetic Medicine. 35(12). 1630–1634. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact